Journal of Research in Medical Sciences最新文献

{"title":"Risk factors for ERCP-related complications and what is the specific role of ASGE grading system.","authors":"Ahmad Shavakhi,&nbsp;Mehdi Zobeiri,&nbsp;Mahsa Khodadoostan,&nbsp;Mohammad Javad Zobeiri,&nbsp;Alireza Shavakhi","doi":"10.4103/jrms.jrms_150_22","DOIUrl":"https://doi.org/10.4103/jrms.jrms_150_22","url":null,"abstract":"<p><strong>Background: </strong>Endoscopic retrograde cholangiopancreatography (ERCP) is one of the main therapeutic and sometimes diagnostic methods in biliary and pancreatic diseases. A grading system for the difficulty of ERCP (grade one to four, the higher grade represents the more complexity of the procedure) has been developed by the American Society for Gastrointestinal Endoscopy (ASGE). This study aimed to assess the prevalence of ERCP-related complications, their common risk factors, and specifically the role of difficulty of the procedure based on ASGE grading.</p><p><strong>Material and methods: </strong>This cross-sectional study was performed on 620 ERCP-operated patients over 4 years in two tertiary referral centers affiliated with Isfahan University of Medical Sciences. Data about the difficulty of procedures based on the ASGE grading scale, complications including pancreatitis, bleeding, infection, perforation, arrhythmia, respiratory suppression, aspiration, and major common risk factors were collected.</p><p><strong>Results: </strong>The overall prevalence of complications was 11.6% including pancreatitis 8.2%, perforation 0.8%, gastrointestinal bleeding 1.3%, cholangitis 2.4%, and cardiopulmonary problems 0.5% (arrhythmia 0.3% and respiratory depression 0.2%). Patients with pancreatic contrast injection (66.7% vs. 11.3% <i>P</i> = 0.04) and sphincter of Oddi dysfunction (SOD) (44.4% vs. 11.1%; <i>P</i> = 0.01) showed a statistically significant higher overall complication rate. The association of these risk factors remained significant in multivariable logistic regression analysis. Patients with pancreatic contrast injection also showed a statistically significant higher prevalence of post-ERCP pancreatitis (66.7% vs. 11.3% <i>P</i> = 0.04). Furthermore, a significantly higher prevalence of arrhythmia (3.6% vs. 0; <i>P</i> = 0.008) was observed among patients with difficult cannulation. Based on the ASGE difficulty grading score, most of the patients were classified as grade 2 (74.2%) and 3 and 4 (23.4%). No statistically significant difference was noted between the difficulty-based groups in terms of complications.</p><p><strong>Conclusion: </strong>The current study showed that the most critical risk factors of ERCP-induced complications were pancreatic contrast injection and SOD. ASGE grading scale for ERCP complexity did not predict the occurrence of complications in our study population.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"7"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3c/c7/JRMS-28-7.PMC10039106.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The value of machine learning for prognosis prediction of diphenhydramine exposure: National analysis of 50,000 patients in the United States.","authors":"Omid Mehrpour,&nbsp;Farhad Saeedi,&nbsp;Jafar Abdollahi,&nbsp;Alireza Amirabadizadeh,&nbsp;Foster Goss","doi":"10.4103/jrms.jrms_602_22","DOIUrl":"https://doi.org/10.4103/jrms.jrms_602_22","url":null,"abstract":"<p><strong>Background: </strong>Diphenhydramine (DPH) is an antihistamine medication that in overdose can result in anticholinergic symptoms and serious complications, including arrhythmia and coma. We aimed to compare the value of various machine learning (ML) models, including light gradient boosting machine (LGBM), logistic regression (LR), and random forest (RF), in the outcome prediction of DPH poisoning.</p><p><strong>Materials and methods: </strong>We used the National Poison Data System database and included all of the human exposures of DPH from January 01, 2017 to December 31, 2017, and excluded those cases with missing information, duplicated cases, and those who reported co-ingestion. Data were split into training and test datasets, and three ML models were compared. We developed confusion matrices for each, and standard performance metrics were calculated.</p><p><strong>Results: </strong>Our study population included 53,761 patients with DPH exposure. The most common reasons for exposure, outcome, chronicity of exposure, and formulation were captured. Our results showed that the average precision-recall area under the curve (AUC) of 0.84. LGBM and RF had the highest performance (average AUC of 0.91), followed by LR (average AUC of 0.90). The specificity of the models was 87.0% in the testing groups. The precision of models was 75.0%. Recall (sensitivity) of models ranged between 73% and 75% with an F1 score of 75.0%. The overall accuracy of LGBM, LR, and RF models in the test dataset was 74.8%, 74.0%, and 75.1%, respectively. In total, just 1.1% of patients (mostly those with major outcomes) received physostigmine.</p><p><strong>Conclusion: </strong>Our study demonstrates the application of ML in the prediction of DPH poisoning.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"49"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0a/ef/JRMS-28-49.PMC10366979.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9872662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of alcohol consumption with the prevalence and various stages of chronic kidney disease.","authors":"Firouzeh Moeinzadeh,&nbsp;Shahrzad Shahidi,&nbsp;Shiva Seirafian,&nbsp;Mohammad Hossein Rouhani,&nbsp;Mojgan Mortazavi,&nbsp;Asieh Maghami-Mehr,&nbsp;Sahar Vahdat","doi":"10.4103/jrms.jrms_152_22","DOIUrl":"https://doi.org/10.4103/jrms.jrms_152_22","url":null,"abstract":"<p><strong>Background: </strong>Considering that the effect of alcohol consumption trend on the prevalence of kidney damage and its progression has not been determined yet, the study aimed at investigating the association between alcohol consumption and the risk of chronic kidney disease (CKD) prevalence and progression at various stages of the disease.</p><p><strong>Materials and methods: </strong>This cross-sectional study was performed on 3374 participants that referred to health-care centers in Isfahan from 2017 to 2019. Participants' basic and clinical characteristics (such as sex, age, education level, marital status, body mass index, blood pressure, alcohol consumption, comorbidities, and laboratory parameters) were evaluated and recorded. The alcohol consumption trend was classified as never, occasional (<6 drinks/week), and frequent (≥6 drinks/week) based on the amount of alcohol consumption over the last 3 months. Moreover, CKD stages were recorded based on the Kidney Disease: Improving Global Outcomes guideline, as well.</p><p><strong>Results: </strong>In the present study, the occasional and frequent drinking of alcohol did not have a significant effect on the odds of CKD prevalence (odds ratio [OR]: 1.32 and 0.54; <i>P</i> > 0.05) and the odds of stage 2 CKD prevalence as compared to stage 1 CKD prevalence (OR: 0.93 and 0.47; <i>P</i> > 0.05). However, adjusting the confounding factors revealed that occasional drinking as compared to nondrinking increased the odds of stage 3 and 4 CKD prevalence as compared to stage 1 CKD prevalence by 3.35 folds, respectively (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>According to the results of this study, occasional drinking as compared to nondrinking significantly increased the odds of stage 3 and 4 CKD prevalence as compared to stage 1 CKD prevalence.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"26"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/67/JRMS-28-26.PMC10199358.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9873603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing preemptive injection of peri-articular-multimodal drug with oral celexocib for postoperative pain management in total knee arthroplasty: A randomized clinical trial.","authors":"Mehdi Motififard,&nbsp;Abolghasem Zarezadeh,&nbsp;Ghasem Mohammadsharifi","doi":"10.4103/jrms.JRMS_208_19","DOIUrl":"https://doi.org/10.4103/jrms.JRMS_208_19","url":null,"abstract":"<p><strong>Background: </strong>Total knee arthroplasty (TKA) is associated with tremendous postoperative pain, and pain relief should concisely be considered. This study aims to compare the efficacy of preemptive periarticular multimodal drug injection versus placebo and oral celecoxib on postoperative pain control after TKA.</p><p><strong>Materials and methods: </strong>This study is a randomized clinical trial on 146 patients candidate for TKA who were randomly allocated to three treatment groups, including (1) a cocktail consisting of bupivacaine, morphine, epinephrine, and ketorolac (<i>n</i> = 48), (2) only epinephrine (placebo group) (<i>n</i> = 49), and (3) 400 mg celecoxib orally (control group) (<i>n</i> = 49) using the Random Allocation software. The injections and oral therapy were performed within 15 min before the surgical procedure. The study's primary outcome was the Knee Society Score (KSS) calculated at baseline, within 6 weeks and 6 months postoperatively. Range of motion (ROM) and Visual Analog Scale (VAS) to assess pain intensity as the other primary outcomes were evaluated before the procedure, within 24 h, 48 h, and 6 weeks postoperatively.</p><p><strong>Results: </strong>The three studied groups were similar regarding demographic characteristics, including age (<i>P</i> = 0.33), gender distribution (<i>P</i> = 0.65), and involved knee side (<i>P</i> = 0.94). Baseline comparison of KSS (<i>P</i> = 0.39), VAS (<i>P</i> = 0.24), and ROM (<i>P</i> = 0.37) among the groups revealed insignificant differences. All the studied groups showed a statistically significant trend of improvement in KSS, VAS, and ROM (<i>P</i> < 0.001), while the comparison of the three groups in terms of KSS (<i>P</i> = 0.001), VAS (<i>P</i> < 0.001), and ROM (<i>P</i> < 0.001) revealed remarkable superiority of multimodal injection to the other treatments.</p><p><strong>Conclusion: </strong>Preemptive periarticular multimodal drug injection, including bupivacaine, morphine, epinephrine, and ketorolac, can cause considerable postoperative pain relief and better ROM achievement in comparison to placebo or oral celecoxib.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"51"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/61/78/JRMS-28-51.PMC10366983.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9882243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of threshold inspiratory muscle training on the duration of weaning in intensive care unit-admitted patients: A randomized clinical trial.","authors":"Farnoosh Khodabandeloo,&nbsp;Razieh Froutan,&nbsp;Arash Peivandi Yazdi,&nbsp;Mohammad Taghi Shakeri,&nbsp;Seyed Reza Mazlom,&nbsp;Ahmad Bagheri Moghaddam","doi":"10.4103/jrms.jrms_757_22","DOIUrl":"https://doi.org/10.4103/jrms.jrms_757_22","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to evaluate the effect of threshold inspiratory muscle training (IMT) on the duration of weaning in intensive care unit (ICU)-admitted patients.</p><p><strong>Materials and methods: </strong>This randomized clinical trial enrolled 79 ICU-admitted, mechanically ventilated patients in 2020-2021 in Imam Reza Hospital, Mashhad. Patients were randomly divided into intervention (<i>n</i> = 40) and control (<i>n</i> = 39) groups. The intervention group received threshold IMT and conventional chest physiotherapy, while the control group only received conventional chest physiotherapy once a day. Before and after the end of the intervention, the strength of inspiratory muscles and the duration of weaning were measured in both the groups.</p><p><strong>Results: </strong>The duration of weaning was shorter in the intervention group (8.4 ± 1.1 days) versus the control group (11.2 ± 0.6 days) (<i>P</i> < 0.001). The rapid shallow breathing index decreased by 46.5% in the intervention group and by 27.3% in the control group after the intervention (both <i>P</i> < 0.001), and the between-group comparison showed a significantly higher reduction in the intervention group than control group (<i>P</i> < 0.001). The patients' compliance after the intervention compared to the 1^st day increased to 16.2 ± 6.6 in the intervention group and 9.6 ± 6.8 in the control group (both <i>P</i> < 0.001), and the between-group comparison showed a significantly higher increase in the intervention group than control group. The maximum inspiratory pressure increased by 13.7 ± 6.1 in the intervention group and by 9.1 ± 6.0 in the control group (<i>P</i> < 0.001). Furthermore, the weaning success was 54% more probable in the intervention group than control group (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The results of this study showed the positive effect of IMT with threshold IMT trainer on increased strength of respiratory muscles and reduced weaning duration.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"44"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/4b/JRMS-28-44.PMC10315402.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST-elevation myocardial infarction: A systematic review and meta-analysis.","authors":"Fanghong Yan,&nbsp;Yuanyuan Zhang,&nbsp;Yayan Pan,&nbsp;Sijun Li,&nbsp;Mengqi Yang,&nbsp;Yutan Wang,&nbsp;Chen Yanru,&nbsp;Wenli Su,&nbsp;Yuxia Ma,&nbsp;Lin Han","doi":"10.4103/jrms.jrms_781_21","DOIUrl":"https://doi.org/10.4103/jrms.jrms_781_21","url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of systematic reviews on the associated factors of mortality among ST-elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI). This meta-analysis was designed to synthesize available evidence on the prevalence and associated factors of mortality after PCI for adult patients with STEMI.</p><p><strong>Materials and methods: </strong>Databases including the Cochrane Library, PubMed, Web of Science, Embase, Ovid, Scopus, ProQuest, MEDLINE, and CINAHL Complete were searched systematically to identify relevant articles published from January 2008 to March 2020 on factors affecting mortality after PCI in STEMI patients. Meta-analysis was conducted using Stata 12.0 software package.</p><p><strong>Results: </strong>Our search yielded 91 cohort studies involving a total of 199, 339 participants. The pooled mortality rate for STEMI patients after PCI was 10%. After controlling for grouping criteria or follow-up time, the following 17 risk factors were significantly associated with mortality for STEMI patients after PCI: advanced age (odds ratio [OR] = 3.89), female (OR = 2.01), out-of-hospital cardiac arrest (OR = 5.55), cardiogenic shock (OR = 4.83), renal dysfunction (OR = 3.50), admission anemia (OR = 3.28), hyperuricemia (OR = 2.71), elevated blood glucose level (OR = 2.00), diabetes mellitus (OR = 1.8), chronic total occlusion (OR = 2.56), Q wave (OR = 2.18), without prodromal angina (OR = 2.12), delay in door-to-balloon time (OR = 1.72), delay in symptom onset-to-balloon time (OR = 1.43), anterior infarction (OR = 1.66), ST-segment resolution (OR = 1.40), and delay in symptom onset-to-door time (OR = 1.29).</p><p><strong>Conclusion: </strong>The pooled prevalence of mortality after PCI for STEMI patients was 10%, and 17 risk factors were significantly associated with mortality for STEMI patients after PCI.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"17"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/de/JRMS-28-17.PMC10098139.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9316598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model.","authors":"Elham Madreseh,&nbsp;Mahmood Mahmoudi,&nbsp;Mohssen Nassiri Toosi,&nbsp;Jamileh Abolghasemi,&nbsp;Hojjat Zeraati","doi":"10.4103/jrms.jrms_1091_21","DOIUrl":"https://doi.org/10.4103/jrms.jrms_1091_21","url":null,"abstract":"<p><strong>Background: </strong>Decompensated cirrhosis patients have a high risk of death which can be considerably reduced with liver transplantation (LT). This study aimed to simultaneously investigate the effect of some patients' characteristics on mortality among those with/without LT and also LT incident.</p><p><strong>Materials and methods: </strong>In this historical cohort study, the information from 780 eligible patients aged 18 years or older was analyzed by the Markov multistate model; they had been listed between 2008 and 2014, needed a single organ for initial orthotopic LT, and followed at least for up to 5 years.</p><p><strong>Results: </strong>With a median survival time of 6 (5-8) years, there were 275 (35%) deaths. From 255 (33%) patients who had LT, 55 (21%) subsequently died. Factors associated with a higher risk of mortality and LT occurrence were included: higher model for end-stage liver disease (MELD) score (hazard ratio [HR] = 1.16, confidence interval [CI]: 1.09-1.24 and HR = 1.22, CI: 1.41-1.30) and ascites complication (HR = 2.34, CI: 1.74-3.16 and HR = 11.43, CI: 8.64-15.12). Older age (HR = 1.03, CI: 1.01-1.06), higher creatinine (HR = 6.87, CI: 1.45-32.56), and autoimmune disease versus hepatitis (HR = 2.53, CI: 1.12-5.73) were associated with increased risk of mortality after LT.</p><p><strong>Conclusion: </strong>The MELD and ascites are influential factors on waiting list mortality and occurrence of LT. Total life expectancy is not influenced by higher MELD.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"28"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/22/JRMS-28-28.PMC10199371.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9505038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of melatonin on cognitive functions following coronary artery bypass grafting: A triple-blind randomized-controlled trial.","authors":"Reza Jouybar,&nbsp;Kambiz Zohoori,&nbsp;Saeed Khademi,&nbsp;Seyed Hedayatallah Akhlagh,&nbsp;Arash Mani,&nbsp;Seyed Amir Reza Akhlagh,&nbsp;Elham Asadpour","doi":"10.4103/jrms.jrms_118_21","DOIUrl":"https://doi.org/10.4103/jrms.jrms_118_21","url":null,"abstract":"<p><strong>Background: </strong>Cognitive dysfunction presents one of the chief causes of postoperative morbidity. Melatonin as a neurohormone can improve neurocognitive functioning and sleep disorders. We evaluated the effect of melatonin on the postoperative cognitive function of patients undergoing coronary artery bypass grafting (CABG).</p><p><strong>Materials and methods: </strong>A triple-blind randomized-controlled trial was conducted on 66 CABG candidates in Namazee Hospital (Shiraz, Iran). Patients were assigned equally into two groups receiving melatonin 10 mg or a placebo daily for 4 weeks before surgery and 2 days after surgery in the intensive care unit. The Mini-Mental State Examination (MMSE), Tower of London (ToL), and Wechsler Adults Intelligence Scale-Revised (WAIS-R) cognitive function tests were performed in both groups 4 weeks before surgery (time point 1), 2 days after surgery (time point 2), and 6 weeks after initial administration of melatonin (time point 3).</p><p><strong>Results: </strong>The mean change score (time point 3-time point 1) differed significantly between the two groups in the MMSE (<i>P</i> ≤ 0.001), ToL total score (<i>P</i> = 0.001), and WAIS-R general IQ (<i>P</i> ≤ 0.001), picture completion (<i>P</i> ≤ 0.001), vocabulary (<i>P</i> = 0.024), and digit span (<i>P</i> = 0.01). On the other hand, no significant differences were detected in the WAIS-R block design, ToL total time delay, ToL total lab, and ToL total result scores.</p><p><strong>Conclusion: </strong>The MMSE and WAIS-R tests revealed that melatonin might have prophylactic effects against postoperative cognitive disturbance in patients undergoing elective CABG.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"14"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/70/78/JRMS-28-14.PMC10098135.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9316599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the effectiveness of tranexamic acid administration in reducing bleeding in benign prostate hyperplasia patients underwent open prostatectomy: A double-blind randomized clinical trial.","authors":"Mehrdad Mohammadi Sichani,&nbsp;Sina Mohammadi,&nbsp;Mohammad Hatef Khorrami,&nbsp;Mahtab Zargham,&nbsp;Amir Javid,&nbsp;Mehdi Dehghani,&nbsp;Farshad Gholipour,&nbsp;Pardis Rafei Dehkordi,&nbsp;Reza Kazemi","doi":"10.4103/jrms.jrms_308_22","DOIUrl":"https://doi.org/10.4103/jrms.jrms_308_22","url":null,"abstract":"<p><strong>Background: </strong>Blood loss of postoperative after prostate surgery could be related with an increase in urinary fibrinolytic activity. Tranexamic acid (TXA) is both a potent inhibitor of plasminogen and urokinase activators and a low molecular weight substance that is excreted unchanged in the urinary tract and can be administered both orally and intravenously. This study aimed to evaluate the effectiveness TXA administration in reducing bleeding in benign prostatic hyperplasia (BPH) patients who underwent open prostatectomy.</p><p><strong>Materials and methods: </strong>This double-blind randomized clinical trial was conducted on patients with BPH who underwent open prostatectomy. The first group received TXA (1 gr IV from during surgery to 48 h after surgery, 3 times/day). Twenty-four hours after surgery, the two groups were compared in terms of bleeding rate. Hemoglobin (Hb), hematocrit (HCT), and platelet (Plt) counts were also assessed before and after the intervention.</p><p><strong>Results: </strong>Intervention and control groups were comparable in terms of basic and baseline values of variables at the beginning of the study (<i>P</i> > 0.05). The mean bleeding volume in TXA group was significantly lower than the control group 112.11 ± 53.5 and 190.00 ± 97.5 CC; <i>P</i> ≤ 0.001). Mean hospitalization (3.28±0.46 vs. 4.38 ± 0.95 days <i>P</i> < 0.001) and surgery duration (98.11 ± 37.11 vs. 128.00 ± 39.12 h; <i>P</i> = 0.001) were significantly lower in TXA group compared to control intervention.</p><p><strong>Conclusion: </strong>According to the findings of the current study, the administration of TXA led to reduce bleeding in BPH patients who underwent open prostatectomy. Furthermore, the mean Hb, HCT, levels were significantly affected by TXA. TXA treatment approach also can reduce the surgery and hospitalization time effectively. TXA approach is recommended as effective procedure in BPH patients who underwent open prostatectomy.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"8"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/0f/JRMS-28-8.PMC10039104.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9552620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>miR-155 rs767649 T>A</i> gene polymorphism is associated with downregulation of <i>miR-155</i> expression, suppressor of cytokine signaling-1 overexpression, and low probability of metastatic tumor at the time of breast cancer diagnosis.","authors":"Sara Iranparast,&nbsp;Maryam Tahmasebi-Birgani,&nbsp;Azim Motamedfar,&nbsp;Afshin Amari,&nbsp;Mehri Ghafourian","doi":"10.4103/jrms.jrms_960_21","DOIUrl":"https://doi.org/10.4103/jrms.jrms_960_21","url":null,"abstract":"<p><strong>Background: </strong><i>MicroRNA-155</i> is a key player in inflammatory reactions, carcinogenesis, and tumor development. In this study, polymorphism of <i>miRNA-155 rs767649 T>A</i> and its gene and suppressor of cytokine signaling-1 (SOCS-1) expression were investigated in relation to cancer susceptibility and development in breast cancer (BC) patients.</p><p><strong>Materials and methods: </strong>Polymorphism of <i>miRNA-155 rs767649 T>A</i> was evaluated between a population of 174 patients with BC and 129 controls using restriction fragment length polymorphism and the expression of <i>miR-155</i> and SOCS-1 were examined in peripheral blood mononuclear cells (PBMCs) by real-time polymerase chain reaction.</p><p><strong>Results: </strong>TT genotype of <i>miR-155 rs767649 T>A</i> was associated with higher level of <i>miR-155</i> in PBMCs of BC patients relative to AT and AA genotypes (21.76 ± 4.4, 4.046 ± 1.35, 2.56 ± 0.81, respectively; <i>P</i> < 0.001) and increased lymph node metastasis (<i>r</i> = 0.292, <i>P</i> = 0.001), not BC susceptibility (<i>P</i> = 0.402 and <i>P</i> = 0.535; respectively). TT genotype of <i>miR-155 rs767649 T>A</i> was associated with less gene expression of SOCS-1 in PBMCs of BC patients compared to AT and AA genotypes (1.173 ± 0.57, 0.92 ± 0.827, 5.512 ± 0.92, respectively; <i>P</i> = 0.003).</p><p><strong>Conclusion: </strong>This study demonstrated for the first time the association between the T allele of the <i>rs767649 T>A</i> polymorphism in the <i>pre-MIR155</i> gene and higher expression of <i>miR-155</i>, lower expression of SOCS-1, and swift latent progression in newly diagnosed BC patients. Thus, <i>miR-155</i> may play a critical role in BC pathogenesis.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"32"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/7f/JRMS-28-32.PMC10199376.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9556431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}